ImmunityBio

News

FDA Allows Use of Recombinant BCG Through Expanded Access Program

Recombinant BCG Offers Fresh Promise in Bladder Cancer Care The U.S. Food and Drug Administration (FDA) has approved a new…

Read More »
Back to top button